Alexander Rabchevsky, PhD

Affiliations: 
University of Kentucky, Lexington, KY 
Google:
"Alexander Rabchevsky"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Malik RN, Samejima S, Shackleton C, et al. (2024) REPORT-SCS: Minimum reporting standards for spinal cord stimulation studies in spinal cord injury. Journal of Neural Engineering
Warner FM, Tong B, McDougall J, et al. (2023) Perspectives on Data Sharing in Persons With Spinal Cord Injury. Neurotrauma Reports. 4: 781-789
Michael FM, Patel SP, Bachstetter AD, et al. (2023) Proinflammatory and Immunomodulatory Gene and Protein Expression Patterns in Spinal Cord and Spleen Following Acute and Chronic High Thoracic Injury. Journal of Inflammation Research. 16: 3341-3349
Patel SP, Michael FM, Gollihue JL, et al. (2022) Delivery of mitoceuticals or respiratory competent mitochondria to sites of neurotrauma. Mitochondrion. 68: 10-14
Hart SN, Patel SP, Michael FM, et al. (2022) Rat Spinal Cord Injury Associated with Spasticity Leads to Widespread Changes in the Regulation of Retained Introns. Neurotrauma Reports. 3: 105-121
Bourbeau D, Bolon A, Creasey G, et al. (2020) Needs, priorities, and attitudes of individuals with spinal cord injury toward nerve stimulation devices for bladder and bowel function: a survey. Spinal Cord
Rabchevsky AG, Michael FM, Patel SP. (2020) Mitochondria focused neurotherapeutics for spinal cord injury. Experimental Neurology. 113332
Michael FM, Patel SP, Rabchevsky AG. (2019) Intraspinal Plasticity Associated With the Development of Autonomic Dysreflexia After Complete Spinal Cord Injury. Frontiers in Cellular Neuroscience. 13: 505
Eldahan KC, Williams HC, Cox DH, et al. (2019) Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury. Experimental Neurology. 113083
Scholpa NE, Williams H, Wang W, et al. (2018) Pharmacological stimulation of mitochondrial biogenesis using the FDA-approved β2-adrenoreceptor agonist formoterol for the treatment of spinal cord injury. Journal of Neurotrauma
See more...